** Shares of laboratory services provider Labcorp Holdings LH.N fall 4.2% to $220.08
** Co posts Q1 revenue of $3.35 bilion, missing analysts' estimate of $3.40 billion, according to data compiled by LSEG
** However, co reports Q1 adj. profit of $3.84 per share, beating analysts' estimate of $3.74 per share
** Co's diagnostic laboratories business grew 6% to $2.63 billion in the quarter
** Co raises lower end of its 2025 profit forecast to $15.70 per share from $15.60 previously, maintains upper end at $16.40 per share
** "While the macroeconomic environment remains dynamic, the critical nature of the work we do in diagnostics and drug development positions us well for success in 2025 and beyond," says CEO Adam Schechter
** As of last close, LH had risen 0.12% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。